Vascular Therapeutics Inc.
Vascular Therapeutics is developing drugs to treat clotting disorders at the molecular level.
You may also be interested in...
The diagnostics company has secured $10m from the foundation to develop a biomarker test for Parkinson’s disease.
Generics Bulletin previews the most noteworthy and anticipated events for December 2023.
After some 10 years of the implementation of the EU’s Medical Device and IVD Regulations being an annual agenda item at December Council of the EU meetings, the scale of problems remains the same.